FDA Drug Recalls

Recalls / Class II

Class IID-0624-2024

Product

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Brand name
Progesterone
Generic name
Progesterone
Active ingredient
Progesterone
Route
Intramuscular
NDC
55150-306
FDA application
ANDA210965
Affected lot / code info
Lot #: CPR230029A

Why it was recalled

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

Recalling firm

Firm
Eugia US LLC
Notification channel
N/A
Type
Voluntary: Firm initiated
Address
279 Princeton Hightstown Rd, N/A, East Windsor, New Jersey 08520-1401

Distribution

Quantity
17136 vials
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2024-07-26
FDA classified
2024-08-01
Posted by FDA
2024-08-07
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0624-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Progesterone · FDA Drug Recalls